CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,692 | -36.9% | 650 | -50.0% | 0.00% | – |
Q2 2023 | $15,359 | +86.4% | 1,300 | +100.0% | 0.00% | – |
Q1 2023 | $8,242 | +39147.6% | 650 | -60.6% | 0.00% | -100.0% |
Q4 2022 | $21 | -99.9% | 1,650 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $21,000 | 0.0% | 1,650 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $21,000 | -27.6% | 1,650 | -28.3% | 0.00% | – |
Q1 2022 | $29,000 | +1350.0% | 2,300 | +253.8% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 650 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | -33.3% | 650 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 650 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | -25.0% | 650 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | -20.0% | 650 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | – | 650 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $8,000 | -27.3% | 1,020 | 0.0% | 0.00% | – |
Q3 2018 | $11,000 | -15.4% | 1,020 | +2.0% | 0.00% | -100.0% |
Q2 2018 | $13,000 | -71.7% | 1,000 | -80.0% | 0.00% | -50.0% |
Q1 2018 | $46,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $46,000 | +15.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $40,000 | +73.9% | 5,000 | +25.0% | 0.00% | +100.0% |
Q2 2017 | $23,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |